Hill Holliday nets Diovan

Share this article:
Novartis shifted the DTC account for Diovan from Deutsch to Hill, Holliday, Connors, Cosmopoulos.

Both Hill Holliday and Deutsch are Interpublic companies. There was no pitch for the business, which will be handled out of Boston-based Hill Holliday's New York office. It's a coup for Hill Holliday, which has been seeking an in on the pharmaceutical sector. Hill Holliday healthcare accounts include CVS and Cleveland Clinic.  

Deutsch continues to handle the rest of Novartis' cardiology franchise, including Lotrel and BP Success Zone. The agency will also handle consumer advertising for two forthcoming Novartis cardiovascular products, due to launch in 2007 and 2008.

The move, first reported by Advertising Age, comes ahead of Novartis' first branded consumer work for Diovan in several years. It was previously incorporated into part of BP Success Zone.
Diovan boasted US sales of $1.3 billion for the nine months to September—up 19% year on year—with total worldwide sales of $3 billion for the period. The company presented data last month to the American Heart Association showing that the drug, given at high doses, could help diabetics. Results from a 391-patient trial showed that the drug reduced protein levels in the urine of patients.

Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.